期刊文献+

S-(+)-(E)-1-(2-furfuryl)-5-substituted-1,3,5-hexahydrotriazine-2-N-nitroimines:Synthesis,Crystal Structure and DFT Calculations 被引量:1

S-(+)-(E)-1-(2-furfuryl)-5-substituted-1,3,5-hexahydrotriazine-2-N-nitroimines:Synthesis,Crystal Structure and DFT Calculations
下载PDF
导出
摘要 A novel neonicotinoid analogue(C13H19N5O5,3a)had been synthesized,the structure was characterized by elemental analysis,IR and 1H NMR spectra,and the S-(+)-(E)-configuration was confirmed by single-crystal X-ray diffraction.The crystal belongs to monoclinic,space group P21 with a = 8.7076(17),b = 8.3211(17),c = 10.642(2),β = 92.370(3)o,V = 770.4(3)3,Z = 2,Dc = 1.402 g/cm3,μ = 0.110 mm-1,Mr = 325.33,F(000)= 344,S = 1.027,R = 0.0543 and wR = 0.1229 for 3601 unique reflections with 2919 observed ones(I 2σ(I)).Compound 3a is stabilized by intramolecular hydrogen bonds and intermolecular force.In addition,the structure of compound 3a was optimized by the B3LYP/6-31G(d,p).DFT/B3LYP optimizations were performed based on X-ray geometries applying 6-31G(d,p)basis set.The optimized structure of compound 3a by the B3LYP/6-31G(d,p)method is more bent than in the crystal.IR spectrum of the solid compound is consistent with the X-ray structure.The HOMO-LUMO gap in 3a(5.3 eV)indicates high kinetic stabilities of compound 3a.The preliminary bioassay test showed that 3a exhibited good activities against Nilaparvata legen,Pseudaletia separate Walker and Aphis medicagini at 500 mg/L. A novel neonicotinoid analogue(C13H19N5O5,3a)had been synthesized,the structure was characterized by elemental analysis,IR and 1H NMR spectra,and the S-(+)-(E)-configuration was confirmed by single-crystal X-ray diffraction.The crystal belongs to monoclinic,space group P21 with a = 8.7076(17),b = 8.3211(17),c = 10.642(2),β = 92.370(3)o,V = 770.4(3)3,Z = 2,Dc = 1.402 g/cm3,μ = 0.110 mm-1,Mr = 325.33,F(000)= 344,S = 1.027,R = 0.0543 and wR = 0.1229 for 3601 unique reflections with 2919 observed ones(I 2σ(I)).Compound 3a is stabilized by intramolecular hydrogen bonds and intermolecular force.In addition,the structure of compound 3a was optimized by the B3LYP/6-31G(d,p).DFT/B3LYP optimizations were performed based on X-ray geometries applying 6-31G(d,p)basis set.The optimized structure of compound 3a by the B3LYP/6-31G(d,p)method is more bent than in the crystal.IR spectrum of the solid compound is consistent with the X-ray structure.The HOMO-LUMO gap in 3a(5.3 eV)indicates high kinetic stabilities of compound 3a.The preliminary bioassay test showed that 3a exhibited good activities against Nilaparvata legen,Pseudaletia separate Walker and Aphis medicagini at 500 mg/L.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2011年第10期1452-1458,共7页 结构化学(英文)
基金 supported by the National Natural Science Foundation of China (21042010) the Key Laboratory of Rare Earth Functional Materials of Shanghai (07dz22303) the Key Scientific and Technological Project of Shanghai (09391912100)
关键词 NEONICOTINOID SYNTHESIS crystal structure DFT calculations hexahydrotriazine neonicotinoid synthesis crystal structure DFT calculations hexahydrotriazine
  • 相关文献

参考文献1

二级参考文献20

  • 1Cheeseman,G.W.H.J.Chem.Soc.1955,77,3308-3310.
  • 2Cheeseman,G.W.H.J.Chem.Soc.1962,84,1170-1176.
  • 3Pflugrath J.W.CryslalClear:Rigaku Corporation 1999.
  • 4Sheldrick,G M.SHELX-97,Program for X-ray Crystal Structure Refinement,Gbuingen University,Germany 1997.
  • 5Petrin D.D.; Armarego,L.F.; Perrin,D.R.Purification of Laboratory Chemicals,2ed,Pergamon Press 1980,p171,1348.
  • 6Chen,X.M.; Cai,J.W.Crystal Structure Analysis,Science Publication,Beijing 2003,p1 14.
  • 7Feng,J.C.Structure Analysis and Identification of Organic Compound,National Defence Industry Publication,Beijing 2004,Chapter 2.
  • 8Gale,P.A.Coord.Chem.Rev.2001,213,79-128
  • 9Sessler,J.L.; Davis,J.M.Acc.Chem.Res.2001,34,989-997
  • 10Beer,P.D.; Gale,P.A.Angew.Chem..Int.Ed.2001,40,486-516

共引文献1

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部